These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 11836128)
1. Phenolic modification as an approach to improve the pharmacology of the 3-acyloxy-2-benzylpropyl homovanillic amides and thioureas, a promising class of vanilloid receptor agonists and analgesics. Lee J; Lee J; Kang MS; Kim KP; Chung SJ; Blumberg PM; Yi JB; Park YH Bioorg Med Chem; 2002 Apr; 10(4):1171-9. PubMed ID: 11836128 [TBL] [Abstract][Full Text] [Related]
2. 3-Acyloxy-2-phenalkylpropyl amides and esters of homovanillic acid as novel vanilloid receptor agonists. Lee J; Park SU; Kim JY; Kim JK; Lee J; Oh U; Marquez VE; Beheshti M; Wang QJ; Modarres S; Blumberg PM Bioorg Med Chem Lett; 1999 Oct; 9(20):2909-14. PubMed ID: 10571146 [TBL] [Abstract][Full Text] [Related]
3. Analysis of structure-activity relationships for the 'B-region' of N-(3-acyloxy-2-benzylpropyl)-N(')-[4-(methylsulfonylamino)benzyl]thiourea analogues as vanilloid receptor antagonists: discovery of an N-hydroxythiourea analogue with potent analgesic activity. Lee J; Kang SU; Choi HK; Lee J; Lim JO; Kil MJ; Jin MK; Kim KP; Sung JH; Chung SJ; Ha HJ; Kim YH; Pearce LV; Tran R; Lundberg DJ; Wang Y; Toth A; Blumberg PM Bioorg Med Chem Lett; 2004 May; 14(9):2291-7. PubMed ID: 15081027 [TBL] [Abstract][Full Text] [Related]
4. N-(3-Acyloxy-2-benzylpropyl)-N'-(4-hydroxy-3-methoxybenzyl) thiourea derivatives as potent vanilloid receptor agonists and analgesics. Lee J; Lee J; Kim J; Kim SY; Chun MW; Cho H; Hwang SW; Oh U; Park YH; Marquez VE; Beheshti M; Szabo T; Blumberg PM Bioorg Med Chem; 2001 Jan; 9(1):19-32. PubMed ID: 11197340 [TBL] [Abstract][Full Text] [Related]
5. N-(3-acyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues: novel potent and high affinity antagonists and partial antagonists of the vanilloid receptor. Lee J; Lee J; Kang M; Shin M; Kim JM; Kang SU; Lim JO; Choi HK; Suh YG; Park HG; Oh U; Kim HD; Park YH; Ha HJ; Kim YH; Toth A; Wang Y; Tran R; Pearce LV; Lundberg DJ; Blumberg PM J Med Chem; 2003 Jul; 46(14):3116-26. PubMed ID: 12825950 [TBL] [Abstract][Full Text] [Related]
6. 3-D-QSAR analysis of N-(3-acyloxy-2-benzylpropyl)-N'-dihydroxytetrahydrobenzazepine and tetrahydroisoquinoline and N-(3-acyloxy-2-benzylpropyl)-N'-(4-hydroxy-3-methoxybenzyl) thioureas analogues as potent vanilloid receptor ligands. Kim KH Bioorg Med Chem; 2002 May; 10(5):1367-72. PubMed ID: 11886800 [TBL] [Abstract][Full Text] [Related]
7. Analysis of structure-activity relationships with the N-(3-acyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea template for vanilloid receptor 1 antagonism. Lee J; Kim SY; Lee J; Kang M; Kil MJ; Choi HK; Jin MK; Wang Y; Toth A; Pearce LV; Lundberg DJ; Tran R; Blumberg PM Bioorg Med Chem; 2004 Jul; 12(13):3411-20. PubMed ID: 15186827 [TBL] [Abstract][Full Text] [Related]
8. N-4-Substituted-benzyl-N'-tert-butylbenzyl thioureas as vanilloid receptor ligands: investigation on the role of methanesulfonamido group in antagonistic activity. Park HG; Choi JY; Choi SH; Park MK; Lee J; Suh YG; Cho H; Oh U; Lee J; Kang SU; Lee J; Kim HD; Park YH; Su Jeong Y; Kyu Choi J; Jew SS Bioorg Med Chem Lett; 2004 Feb; 14(3):787-91. PubMed ID: 14741290 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of simplified resiniferatoxin analogues with potent VR1 agonism elucidates an active conformation of RTX for VR1 binding. Lee J; Kim SY; Park S; Lim JO; Kim JM; Kang M; Lee J; Kang SU; Choi HK; Jin MK; Welter JD; Szabo T; Tran R; Pearce LV; Toth A; Blumberg PM Bioorg Med Chem; 2004 Mar; 12(5):1055-69. PubMed ID: 14980619 [TBL] [Abstract][Full Text] [Related]
10. N-(3-acyloxy-2-benzylpropyl)-N'-dihydroxytetrahydrobenzazepine and tetrahydroisoquinoline thiourea analogues as vanilloid receptor ligands. Lee J; Lee J; Szabo T; Gonzalez AF; Welter JD; Blumberg PM Bioorg Med Chem; 2001 Jul; 9(7):1713-20. PubMed ID: 11425572 [TBL] [Abstract][Full Text] [Related]
11. Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 2. The amide bond "B-region". Walpole CS; Wrigglesworth R; Bevan S; Campbell EA; Dray A; James IF; Masdin KJ; Perkins MN; Winter J J Med Chem; 1993 Aug; 36(16):2373-80. PubMed ID: 8360882 [TBL] [Abstract][Full Text] [Related]
12. Novel potent antagonists of transient receptor potential channel, vanilloid subfamily member 1: structure-activity relationship of 1,3-diarylalkyl thioureas possessing new vanilloid equivalents. Suh YG; Lee YS; Min KH; Park OH; Kim JK; Seung HS; Seo SY; Lee BY; Nam YH; Lee KO; Kim HD; Park HG; Lee J; Oh U; Lim JO; Kang SU; Kil MJ; Koo JY; Shin SS; Joo YH; Kim JK; Jeong YS; Kim SY; Park YH J Med Chem; 2005 Sep; 48(18):5823-36. PubMed ID: 16134949 [TBL] [Abstract][Full Text] [Related]
13. Heterocycle-linked phenylbenzyl amides as novel TRPV1 antagonists and their TRPV1 binding modes: constraint-induced enhancement of in vitro and in vivo activities. Kim NJ; Li FN; Lee JH; Park SG; Kim K; Lim C; Han YT; Yun H; Jung JW; Park HG; Kim HD; Woo BY; Shin SS; Kim SY; Choi JK; Jeong YS; Park Y; Park YH; Kim DD; Choi S; Suh YG Chem Asian J; 2013 Feb; 8(2):400-9. PubMed ID: 23208797 [TBL] [Abstract][Full Text] [Related]
14. Guanidinium and aminoimidazolinium derivatives of N-(4-piperidyl)propanamides as potential ligands for mu opioid and I2-imidazoline receptors: synthesis and pharmacological screening. Montero A; Goya P; Jagerovic N; Callado LF; Meana JJ; Girón R; Goicoechea C; Martín MI Bioorg Med Chem; 2002 Apr; 10(4):1009-18. PubMed ID: 11836109 [TBL] [Abstract][Full Text] [Related]
15. Discovery of novel 5,5-diarylpentadienamides as orally available transient receptor potential vanilloid 1 (TRPV1) antagonists. Saku O; Ishida H; Atsumi E; Sugimoto Y; Kodaira H; Kato Y; Shirakura S; Nakasato Y J Med Chem; 2012 Apr; 55(7):3436-51. PubMed ID: 22394104 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB₂ receptor agonists for pain management. Nelson DW; Frost JM; Tietje KR; Florjancic AS; Ryther K; Carroll WA; Dart MJ; Daza AV; Hooker BA; Grayson GK; Fan Y; Garrison TR; El-Kouhen OF; Yao B; Pai M; Chandran P; Zhu C; Hsieh GC; Meyer MD Bioorg Med Chem Lett; 2012 Apr; 22(7):2604-8. PubMed ID: 22370265 [TBL] [Abstract][Full Text] [Related]
17. Dopamides, vanillylamides, ethanolamides, and arachidonic acid amides of anti-inflammatory and analgesic drug substances as TRPV1 ligands. Sinning C; Watzer B; De Petrocellis L; Di Marzo V; Imming P ChemMedChem; 2008 Dec; 3(12):1956-64. PubMed ID: 19003845 [TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships and molecular modeling of the N-(3-pivaloyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl] thiourea template for TRPV1 antagonism. Bhondwe RS; Kang DW; Kim MS; Kim HS; Park SG; Son K; Choi S; Kuhs KA; Pavlyukovets VA; Pearce LV; Blumberg PM; Lee J Bioorg Med Chem Lett; 2012 Jun; 22(11):3656-60. PubMed ID: 22546668 [TBL] [Abstract][Full Text] [Related]
19. N-4-methansulfonamidobenzyl-N'-2-substituted-4-tert-butyl-benzyl thioureas as potent vanilloid receptor antagonistic ligands. Park HG; Choi JY; Choi SH; Park MK; Lee J; Suh YG; Cho H; Oh U; Kim HD; Joo YH; Kim SY; Park YH; Jeong YS; Choi JK; Kim JK; Jew SS Bioorg Med Chem Lett; 2004 Apr; 14(7):1693-6. PubMed ID: 15026052 [TBL] [Abstract][Full Text] [Related]
20. Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides. Biswas K; Li A; Chen JJ; D'Amico DC; Fotsch C; Han N; Human J; Liu Q; Norman MH; Riahi B; Yuan C; Suzuki H; Mareska DA; Zhan J; Clarke DE; Toro A; Groneberg RD; Burgess LE; Lester-Zeiner D; Biddlecome G; Manning BH; Arik L; Dong H; Huang M; Kamassah A; Loeloff R; Sun H; Hsieh FY; Kumar G; Ng GY; Hungate RW; Askew BC; Johnson E J Med Chem; 2007 May; 50(9):2200-12. PubMed ID: 17408249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]